NCT03719482View on ClinicalTrials.gov

Assessment of the Biodistribution and Safety of [18F]MNI-1054

PHASE1CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

[18F]MNI-1054

Healthy Volunteers recruited for the study will undergo a single \[18F\]MNI-1054 injection and PET scan.

Trial Locations (1)

06510

Invicro, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Invicro

OTHER